Literature DB >> 2161824

Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.

F Derouin, C Chastang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161824     DOI: 10.1093/jac/25.4.708

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.

Authors:  S Jaruratanasirikul; R Hortiwakul; T Tantisarasart; N Phuenpathom; S Tussanasunthornwong
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Diagnosis and Treatment of Toxoplasmosis of the CNS in Patients with AIDS.

Authors:  C Katlama
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

3.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 4.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 5.  Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D H Peters; S P Clissold
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

6.  Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.

Authors:  F Derouin; R Almadany; F Chau; B Rouveix; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.

Authors:  S Romand; M Pudney; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.

Authors:  F G Araujo; P Prokocimer; T Lin; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

9.  Antileishmanial Activity of Liposomal Clarithromycin against Leishmania Major Promastigotes.

Authors:  Ameneh Sazgarnia; Naghmeh Zabolinejad; Pouran Layegh; Omid Rajabi; Fariba Berenji; Zari Javidi; Roshanak Salari
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.